Tyler Buckner, MD
University of North Carolina at Chapel Hill
Dr. Tyler Buckner is a native of Tullahoma, TN, and a graduate of Rhodes College in Memphis, TN. He completed medical school and residency in Internal Medicine and Pediatrics at the University of North Carolina at Chapel Hill, where he also completed a combined fellowship in adult hematology and pediatric hematology/oncology in June 2013. Dr. Buckner will continue to work at UNC as a member of the School of Medicine faculty. His research training includes a National Research Service Award postdoctoral fellowship at the UNC Cecil G. Sheps Center for Health Services Research, as well as didactic coursework that will lead to a Master’s of Science degree in Clinical Research from the UNC Gillings School of Global Public Health. As a hematologist and health services researcher, Tyler aims to study patient-centered methods for improving the delivery of healthcare services to individuals with hemophilia. Dr. Buckner’s current research efforts are focused on improving the management of chronic pain in persons with hemophilia.
Christopher Ng, MD
University of Colorado Denver
Dr. Christopher Ng is a pediatric hematology/oncology fellow at the University of Colorado – Anschutz Medical Campus. Dr. Ng attended medical school at the Keck School of Medicine at the University of Southern California and completed his pediatrics residency at the University of Washington/Seattle Children’s Hospital. Dr. Ng chose to pursue his fellowship training in Colorado due to the presence of the University of Colorado Hemophilia and Thrombosis Center and its commitment to clinical care and hemostasis-based research. As an NHF-Baxter Fellow, Dr. Ng will train under the mentorship of Dr. Marilyn Manco-Johnson. Dr. Ng will receive dedicated training in the care of patients with bleeding and clotting disorders and will continue with his research projects involving the role of von Willebrand Factor (VWF) in hemostatic and thrombotic diseases. Dr. Ng career goals are to focus on the care of pediatric patients with bleeding and clotting disorders through clinical care and academic research.
Click Here to Learn About the
Previously Funded Recipients
Institutional Application Deadline: March 17, 2014
Candidate Application: March 17, 2014
Award Start Date: July 1, 2014
The National Hemophilia Foundation-Baxter Clinical Fellowship Program, funded through the generous support of Baxter Healthcare Corporation, is intended to increase the number of skilled clinicians committed to providing comprehensive care for individuals with bleeding and clotting disorders. The program is designed to provide hands-on clinical training to licensed physicians not to mention prepare them for academic careers in bleeding and clotting disorders research. Mentored training takes place at highly-qualified hemophilia and thrombophilia treatment centers located throughout the United States. Funding is provided to cover costs associated with training promising physicians who show interest in devoting their careers to the care of patients with hemophilia and other bleeding or clotting disorders.
The NHF-Baxter Clinical Fellowship program has provided support to 26 physicians to date. Selections are made by an independent peer review panel and award recipients are able to receive up to $200,000 for a maximum period of two years. Baxter has continued to support this program since its inception in 2003, providing NHF with the ability to select two new clinical fellows each year.
In the field of rare disorders, hemophilia has long been touted as a model for medical care delivery since the majority of patients benefit from treatment in comprehensive care centers. However, this highly specialized care system has become increasingly fragile as a generation of HTC physicians either retire or choose to leave the field. Such departures are accelerating as an ironic byproduct of the HTC success story: More and more patients receive prophylaxis and preventative care; more individuals are able to infuse themselves at home, resulting in a reduction of patient-doctor contact hours. This situation, coupled with a relatively stable to low number of hemophilia patients, has imperiled the profession as a viable full-time practice. Other more systemic problems have included the lack of comprehensive training programs for bleeding disorder specialists and reduced institutional support for hemophilia clinical care and research. Amidst these concerns, there also exists an inadequate system for meeting the needs of individuals affected by thrombosis and inherited thrombophilias. One proposed solution for meeting these patients’ needs is to support the training of physicians who are skilled in the treatment of both conditions at specially-designated care centers. NHF and Baxter firmly believe that this solution offers the means to further increase the number of quality treatment centers, the number of providers attracted to this field and also spur institutional support.
How to Apply
Individual nominations for the NHF-Baxter Clinical Fellowship can only be made by institutions that have already received approval (or are in the process of applying) to participate in the program. Please click on the links below for more detailed instructions and eligibility requirements on both applications:
Step One: Institutional Application – This application is intended for the medical director(s) and other senior faculty members/administrators affiliated with U.S. hemophilia and thrombophilia treatment centers not yet approved to participate in the NHF-Baxter Clinical Fellowship Program. Only authorized institutions may subsequently nominate and train NHF-Baxter Clinical Fellows. If approved, authorization is granted for a period of five years. Approved institutions must submit a re-application every five years, subject to review and approval, in order to continue their participation in the NHF-Baxter Clinical Fellows Program.
Step Two: Candidate Application – This application is intended for the medical director(s) and other senior faculty members/administrators from approved U.S. hemophilia and thrombophilia treatment centers to nominate qualified candidates as NHF-Baxter Clinical Fellows. From among these candidates, two NHF-Baxter Clinical Fellows are selected each year and awarded up to $100,000 per year, for up to two years.
Download Appendix A.
Click here to see a current list of approved institutions participating in the NHF-Baxter Clinical Fellowship Program.
For further information, please contact:
Director, Research and Medical Information
116 West 32nd Street, 11th floor
New York, NY 10001
Phone: (212) 328-3727 or (800) 42-HANDI
Fax: (212) 328-3799